Lipid profiles reveal sex differences in type 2 diabetes
Type 2 diabetes, or T2D, is a metabolic disorder that affects global communities disproportionally. For example, South Asians face a particularly high risk. Changes in lipid species affect T2D, but scientists have not identified any reliable lipid biomarkers. Fatty acids, or FAs, are the major components of many lipids, and they can be potential lipid biomarkers. However, conflicting findings have left unclear how essential FAs relate to T2D development.
In a recent study in the Journal of Lipid Research, Madhusmita Rout and a team of researchers at the University of Oklahoma Health Sciences Center investigated the lipid profiles of individuals from a well-characterized cohort of Asian Indians. They found that in T2D, levels of two key cell membrane components — sphingomyelin and phosphatidylcholines — decreased, while free FAs and lysophosphatidylcholines, or LPCs, increased. After adjusting for age, sex and body mass index, or BMI, they saw significant increases in several essential FAs, such as the omega-6 FA arachidonic acid and the omega-3 FA docosahexaenoic acid. However, in obese individuals, most omega-3 and omega-6 FAs were reduced two- to six-fold. The team also observed sex- and age-related lipid differences. For example, one LPC type was elevated in men of all ages but rose in women only after menopause.
Ultimately, this study identified potentially useful lipid biomarkers that could possibly affect the development of T2D and obesity. Future directions include clarifying the relationship between omega FAs and T2D, as well as the role of essential FAs in human metabolic diseases.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.
Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.
Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.
The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.
Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.
Catching tau in the act
Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.